Product Information
LEUPROLIDE 2WK 14 MG/2.8 ML KT is a generic product labeled by VGYAAN Pharmaceuticals LLC, priced at $261.3184 per EA under NDC 72664061128. Its NADAC has been published 94 times since Apr 17, 2024.
FDA first approved this application on Aug 13, 2021. Its Orange Book therapeutic-equivalence code is AP.
The High Outlier badge above means this manufacturer's average price in the Leuprolide Acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
VGYAAN Pharmaceuticals LLCNDC
72664061128
Classification
Generic
Dosage Form
KIT
Effective Date
1/21/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA213829FDA Approved
8/13/2021
TE Code
AP
On Market Since
10/25/2020
Price Statistics
The NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has been published 94 times since Apr 17, 2024, and over the history we have for it it has risen 13.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $261.3184 per EA |
|---|---|
| All-time high | $301.8717 (Sep 10, 2025) |
| All-time low | $217.5983 (Jul 17, 2024) |
| 52-week high | $301.8717 |
| 52-week low | $241.4400 |
| Median price | $264.5017 |
| Average price | $265.9443 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 94 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-13.4%
3Y
N/A
5Y
N/A
All
+13.4%
Last surveyed Jan 28, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEUPROLIDE 2WK 14 MG/2.8 ML KT?
The current National Average Drug Acquisition Cost (NADAC) for LEUPROLIDE 2WK 14 MG/2.8 ML KT, manufactured by VGYAAN Pharmaceuticals LLC, is $261.3184 per EA (NDC 72664061128), effective Jan 28, 2026.
How has the price of LEUPROLIDE 2WK 14 MG/2.8 ML KT changed over time?
Over the history we have for it, the NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has risen 13.4%. It has been tracked across 94 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for LEUPROLIDE 2WK 14 MG/2.8 ML KT?
Since Apr 17, 2024, the NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has ranged from a low of $217.5983 (Jul 17, 2024) to a high of $301.8717 (Sep 10, 2025), with a median of $264.5017 per EA.
Are there cheaper alternatives to LEUPROLIDE 2WK 14 MG/2.8 ML KT?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEUPROLIDE 2WK 14 MG/2.8 ML KT, is $197.6060 per EA — about 24% below LEUPROLIDE 2WK 14 MG/2.8 ML KT.
Who manufactures LEUPROLIDE 2WK 14 MG/2.8 ML KT?
LEUPROLIDE 2WK 14 MG/2.8 ML KT (NDC 72664061128) is labeled by VGYAAN Pharmaceuticals LLC, and CMS classifies it as a generic product.